Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging-Reference-Cited by-同舟云学术

Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging

Published:2019-08-14 Issue:12 Volume:46 Page:2590-2600
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Katsikis Athanasios,Kyrozi Elena,Manira Vasiliki,Theodorakos Athanasios,Malamitsi Julia,Tsapaki Virginia,Iakovou Ioannis,Voudris Vasilios,Kolovou Genovefa,Koutelou Maria

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04463-9.pdf

Reference27 articles.

1. 2013 American Society of Nuclear Cardiology / MedAxiom Nuclear Survey. J Nucl Cardiol. 2014;21(Suppl 1):5–88. doi: https://doi.org/10.1007/s12350-014-9862-z .

2. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58. https://doi.org/10.1016/j.nuclcard.2007.06.114 .

3. Mahmarian JJ, Peterson LE, Xu J, Cerqueira MD, Iskandrian AE, Bateman TM, et al. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol. 2015;22:248–61. https://doi.org/10.1007/s12350-014-9981-6 .

4. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging. 2008;1:307–16. https://doi.org/10.1016/j.jcmg.2008.02.003 .

5. Iqbal FM, Hage FG, Ahmed A, Dean PJ, Raslan S, Heo J, et al. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. JACC Cardiovasc Imaging. 2012;5:1014–21. https://doi.org/10.1016/j.jcmg.2012.04.009 .

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison;Experimental and Therapeutic Medicine;2023-03-16

2. Comparison of Regadenoson and Dipyridamole Safety Profile During Stress Myocardial Perfusion Imaging;Molecular Imaging and Radionuclide Therapy;2022-09-09

3. Safety and tolerability of regadenoson compared with dipyridamole in myocardial perfusion imaging in patients scheduled to undergo medium to high-risk noncardiac surgery: a randomized controlled study;Nuclear Medicine Communications;2021-12-13

4. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET;Journal of Nuclear Cardiology;2021-08-13

5. Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: Data from a multicentre prospective registry;The International Journal of Cardiovascular Imaging;2021-07-31